Taurus Asset Management’s Novartis NVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-2,600
| Closed | -$237K | – | 96 |
|
|
2021
Q2 | $237K | Sell |
2,600
-1,150
| -31% | -$102K | 0.02% | 93 |
|
|
2021
Q1 | $321K | Sell |
3,750
-2,550
| -40% | -$229K | 0.04% | 74 |
|
|
2020
Q4 | $595K | Sell |
6,300
-2,550
| -29% | -$223K | 0.07% | 60 |
|
|
2020
Q3 | $770K | Hold |
8,850
| – | – | 0.1% | 59 |
|
|
2020
Q2 | $773K | Sell |
8,850
-400
| -4% | -$34.5K | 0.11% | 58 |
|
|
2020
Q1 | $763K | Hold |
9,250
| – | – | 0.13% | 59 |
|
|
2019
Q4 | $876K | Sell |
9,250
-250
| -3% | -$22.4K | 0.11% | 62 |
|
|
2019
Q3 | $826K | Sell |
9,500
-250
| -3% | -$22.4K | 0.12% | 60 |
|
|
2019
Q2 | $890K | Sell |
9,750
-1,131
| -10% | -$95.7K | 0.12% | 59 |
|
|
2019
Q1 | $937K | Sell |
10,881
-2,935
| -21% | -$236K | 0.13% | 59 |
|
|
2018
Q4 | $1.06M | Buy |
13,816
+33
| +0.2% | +$2.57K | 0.17% | 56 |
|
|
2018
Q3 | $1.06M | Sell |
13,783
-111
| -0.8% | -$8.21K | 0.14% | 62 |
|
|
2018
Q2 | $940K | Hold |
13,894
| – | – | 0.14% | 64 |
|
|
2018
Q1 | $1.01M | Sell |
13,894
-949
| -6% | -$72.2K | 0.15% | 63 |
|
|
2017
Q4 | $1.12M | Sell |
14,843
-335
| -2% | -$25.3K | 0.16% | 62 |
|
|
2017
Q3 | $1.17M | Sell |
15,178
-781
| -5% | -$59K | 0.18% | 60 |
|
|
2017
Q2 | $1.19M | Sell |
15,959
-1,562
| -9% | -$111K | 0.19% | 61 |
|
|
2017
Q1 | $1.17M | Sell |
17,521
-3,125
| -15% | -$208K | 0.19% | 62 |
|
|
2016
Q4 | $1.35M | Sell |
20,646
-2,009
| -9% | -$130K | 0.24% | 58 |
|
|
2016
Q3 | $1.6M | Sell |
22,655
-1,395
| -6% | -$102K | 0.29% | 52 |
|
|
2016
Q2 | $1.78M | Sell |
24,050
-223
| -0.9% | -$15.4K | 0.31% | 48 |
|
|
2016
Q1 | $1.58M | Sell |
24,273
-223
| -0.9% | -$15.2K | 0.29% | 53 |
|
|
2015
Q4 | $1.89M | Hold |
24,496
| – | – | 0.35% | 50 |
|
|
2015
Q3 | $2.02M | Sell |
24,496
-112
| -0.5% | -$9.97K | 0.39% | 53 |
|
|
2015
Q2 | $2.17M | Sell |
24,608
-56
| -0.2% | -$5.14K | 0.39% | 56 |
|
|
2015
Q1 | $2.18M | Hold |
24,664
| – | – | 0.41% | 55 |
|
|
2014
Q4 | $2.05M | Sell |
24,664
-558
| -2% | -$46.3K | 0.37% | 59 |
|
|
2014
Q3 | $2.13M | Sell |
25,222
-223
| -0.9% | -$18K | 0.41% | 59 |
|
|
2014
Q2 | $2.06M | Sell |
25,445
-312
| -1% | -$24.5K | 0.4% | 62 |
|
|
2014
Q1 | $1.96M | Hold |
25,757
| – | – | 0.41% | 59 |
|
|
2013
Q4 | $1.85M | Sell |
25,757
-1,278
| -5% | -$88.8K | 0.38% | 64 |
|
|
2013
Q3 | $1.86M | Sell |
27,035
-43,664
| -62% | -$2.89M | 0.43% | 64 |
|
|
2013
Q2 | $4.48M | Buy |
+70,699
| New | +$4.6M | 1.06% | 44 |
|
Other funds holding NVS
Taurus Asset Management's NVS Position: Q3 2021 in Review
Taurus Asset Management sold out of Novartis (NVS) in Q3 2021, closing a stake of 2,600 shares — an estimated $237K sold.
Taurus Asset Management first reported a position in NVS in Q2 2013 and held it in 33 quarters. The position peaked at $4.48M in Q2 2013. 1,081 funds tracked by Wall St. Rank hold NVS as of Q3 2021.
- Taurus Asset Management reported no remaining Novartis position as of Q3 2021 after selling out during the quarter.
- Taurus Asset Management sold 2,600 Novartis shares in Q3 2021, an estimated $237K.
- Taurus Asset Management first reported a position in Novartis in Q2 2013 and held it in 33 quarters.
- Taurus Asset Management's Novartis position peaked at $4.48M in Q2 2013.
- 1,081 funds tracked by Wall St. Rank held Novartis as of Q3 2021.
Based on Taurus Asset Management's 13F filing for Q3 2021, filed 15 Nov 2021.